INIS
patients
100%
drugs
82%
rats
51%
evaluation
46%
hospitals
42%
control
39%
comparative evaluations
37%
doses
36%
diseases
33%
males
25%
india
25%
levels
23%
hiv
21%
females
20%
data
20%
therapy
19%
assessments
19%
mice
18%
learning
17%
risks
16%
pharmacology
16%
blood
14%
animals
13%
teaching
12%
antidepressants
11%
humans
11%
liver
10%
cancer
10%
adults
10%
hypertension
10%
reviews
10%
diabetes mellitus
9%
mortality
9%
death
9%
tuberculosis
9%
management
9%
populations
9%
values
9%
toxicity
9%
cholesterol
8%
administration
8%
sex
8%
glucose
8%
correlations
8%
safety
8%
symptoms
7%
attitudes
7%
clinical trials
7%
kidneys
7%
diuretics
7%
fasting
7%
malaria
6%
creatinine
6%
fruits
6%
viruses
6%
performance
6%
antioxidants
6%
exercise
6%
interactions
6%
damage
6%
antibiotics
6%
reduction
6%
cardiovascular diseases
6%
inflammation
5%
pediatrics
5%
urea
5%
lipids
5%
weight
5%
children
5%
tools
5%
lectures
5%
diet
5%
ulcers
5%
laboratories
5%
insulin
5%
streptozotocin
5%
nervous system diseases
5%
injuries
5%
education
5%
Medicine and Dentistry
Patient
31%
Analysis
17%
Hospital
17%
Global Disease Burden
15%
Age
15%
Therapeutic Procedure
13%
Drug
11%
Chemotherapeutic Agent
11%
Incidence
9%
Prevalence
9%
Tertiary Care
9%
Female
9%
Mortality
8%
Human Immunodeficiency Virus
8%
Male
7%
Diabetes Mellitus
7%
Death
6%
Adverse Event
6%
Disability Adjusted Life Years
6%
Malignant Neoplasm
6%
Medical Student
6%
Inpatient
5%
Diabetes
5%
Geriatrics
5%
Vaccine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
30%
Rat
16%
Wistar Rat
15%
HIV
12%
Adverse Event
11%
Diabetes Mellitus
10%
Toxicity
7%
Prevalence
6%
Diseases
6%
Adverse Drug Reaction
6%
Antihypertensive Agent
5%
Gentamicin
5%
Antidiabetic Agent
5%